AstraZeneca, Sputnik Light Combo Causes Strong Neutralizing Antibody Response, RDIF Says

MOSCOW (Sputnik) - The preliminary results of a clinical study of the combined use of the AstraZeneca and Sputnik Light coronavirus vaccines, carried out by the Russian Direct Investment Fund (RDIF), AstraZeneca and R-Pharm in Azerbaijan, show a strong neutralizing antibody response in the majority of participants, RDIF said on Monday.